Embolic Agents: Sclerotherapy

Author:

Lim Christina1,Lee Sean2,Ghosh Abheek3,Funaki Brian4

Affiliation:

1. Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, Creighton University School of Medicine, Baltimore, Maryland

2. Touro College of Osteopathic Medicine, New York City, New York

3. Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland

4. Division of Vascular and Interventional Radiology, University of Chicago Medicine, Chicago, Illinois

Publisher

Georg Thieme Verlag KG

Reference24 articles.

1. A history of injection treatments - II sclerotherapy;K Myers;Phlebology,2019

2. Sclerotherapy - from historical research to the modern and efficient method of phlebological treatment;J Borecka-Sobczak;Phlebological Rev,2021

3. Pharmacology of sclerotherapy;G Albanese;Semin Intervent Radiol,2010

4. Sclerosis of the great saphenous vein: an experimental study in humans of the sclerosing effect of an iodo-iodide solution and polidodecane (histology and electron microscopy);S Mancini;Phlébologie (Paris),1991

5. Sclerotherapy contraindications, sequelaes, and complications - informing patients properly and objectively is required;T R Urbanek;Phlebological Rev,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3